WallStreetZenWallStreetZen

NASDAQ: NTLA
Intellia Therapeutics Inc Stock Ownership - Who owns Intellia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Intellia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John M. LeonardPresident and CEO2025-12-128,557$6.83
$58.44kBuy
John M. LeonardPresident and CEO2025-12-1149,959$6.83
$341.22kBuy
John M. LeonardPresident and CEO2025-12-1149,959$9.49
$474.11kSell
John M. LeonardPresident and CEO2025-12-115,355$9.59
$51.35kSell
John M. LeonardPresident and CEO2025-12-1132,832$9.47
$310.92kSell
Michael P. DubeVP Chief Accounting Officer2025-10-011,871$17.38
$32.52kSell
Birgit C. SchultesEVP Chief Scientific Officer2025-10-0131$17.38
$538.78Sell
William J. ChaseDirector2025-08-20100,000$10.03
$1.00MBuy
Edward J. Dulac IiiEVP Chief Financial Officer2025-07-237,462$14.02
$104.62kSell
Michael P. DubeVP Chief Accounting Officer2025-07-022,503$9.95
$24.90kSell

1 of 3

NTLA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NTLA insiders and whales buy or sell their stock.

NTLA Shareholders

What type of owners hold Intellia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC10.29%11,919,178$113.83MInstitution
Vanguard Group Inc9.54%11,044,820$105.48MInstitution
Blackrock Inc8.01%9,275,817$88.58MInstitution
Morgan Stanley5.20%6,022,576$57.52MInstitution
Contrarius Group Holdings Ltd5.08%5,889,936$56.25MInstitution
Rachel E. Haurwitz4.83%5,593,846$53.42MInsider
Caribou Therapeutics Holdco LLC4.83%5,593,846$53.42MInsider
State Street Corp4.29%4,970,869$47.47MInstitution
Novartis Institutes For Biomedical Research Inc3.76%4,352,295$41.56MInsider
Goldman Sachs Group Inc3.69%4,278,677$40.86MInstitution

1 of 3

NTLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NTLA72.74%27.26%Net SellingNet Selling
PHAT65.65%34.35%Net SellingNet Selling
GLUE33.23%66.77%Net Buying
NVAX63.49%17.11%Net SellingNet Selling
ERAS71.43%28.57%
View Top Biotech Stocks

Intellia Therapeutics Stock Ownership FAQ

Who owns Intellia Therapeutics?

Intellia Therapeutics (NASDAQ: NTLA) is owned by 89.93% institutional shareholders, 33.70% Intellia Therapeutics insiders, and 0.00% retail investors. Rachel E. Haurwitz is the largest individual Intellia Therapeutics shareholder, owning 5.59M shares representing 4.83% of the company. Rachel E. Haurwitz's Intellia Therapeutics shares are currently valued at $50.46M.

If you're new to stock investing, here's how to buy Intellia Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.